IL280340B - Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections - Google Patents

Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections

Info

Publication number
IL280340B
IL280340B IL280340A IL28034021A IL280340B IL 280340 B IL280340 B IL 280340B IL 280340 A IL280340 A IL 280340A IL 28034021 A IL28034021 A IL 28034021A IL 280340 B IL280340 B IL 280340B
Authority
IL
Israel
Prior art keywords
peptides
antibodies
prevention
combinations
treatment
Prior art date
Application number
IL280340A
Other languages
Hebrew (he)
Inventor
Shulman Ziv
David Mazor Roei
Stoler-Barak Liat
ASAF Lihee
Nathan Nachum
KAGAN BEN TIKVA Sharon
Original Assignee
Yeda Res & Dev
Shulman Ziv
David Mazor Roei
Liat Stoler Barak
ASAF Lihee
Nathan Nachum
KAGAN BEN TIKVA Sharon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Shulman Ziv, David Mazor Roei, Liat Stoler Barak, ASAF Lihee, Nathan Nachum, KAGAN BEN TIKVA Sharon filed Critical Yeda Res & Dev
Priority to IL280340A priority Critical patent/IL280340B/en
Priority to PCT/IL2022/050088 priority patent/WO2022157774A1/en
Publication of IL280340B publication Critical patent/IL280340B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/102—Coronaviridae (F)
    • C07K16/104—Severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
IL280340A 2021-01-21 2021-01-21 Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections IL280340B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL280340A IL280340B (en) 2021-01-21 2021-01-21 Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
PCT/IL2022/050088 WO2022157774A1 (en) 2021-01-21 2022-01-20 Antibodies, peptides and combinations of same for the treatment or prevention of coronavirus infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL280340A IL280340B (en) 2021-01-21 2021-01-21 Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections

Publications (1)

Publication Number Publication Date
IL280340B true IL280340B (en) 2022-04-01

Family

ID=80446372

Family Applications (1)

Application Number Title Priority Date Filing Date
IL280340A IL280340B (en) 2021-01-21 2021-01-21 Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections

Country Status (2)

Country Link
IL (1) IL280340B (en)
WO (1) WO2022157774A1 (en)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (en) 1971-02-10 1977-09-15 Organon Nv METHOD FOR THE DETERMINATION AND DETERMINATION OF SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES.
NL154598B (en) 1970-11-10 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
NL154599B (en) 1970-12-28 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES, AND TEST PACKAGING.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (en) 1972-05-11 1983-06-01 Akzo Nv METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4036945A (en) 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
CA2279547A1 (en) 1997-01-31 1998-08-06 University Of Rochester Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
WO2018081318A1 (en) * 2016-10-25 2018-05-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion coronavirus spike proteins and their use
CN111337672B (en) * 2020-05-18 2020-09-08 博奥赛斯（天津）生物科技有限公司 Novel enzyme-linked immunosorbent assay detection kit for coronavirus IgG antibody
CN111961138B (en) * 2020-10-20 2021-03-30 苏州茂行生物科技有限公司 Vaccine fusion protein

Also Published As

Publication number Publication date
WO2022157774A1 (en) 2022-07-28

Similar Documents

Publication Publication Date Title
EA202091130A1 (en) LYOPHILIZED PREPARATION OF MONOCLONAL ANTIBODY TO TRANSTYRETIN
EP3996716C0 (en) Connections for the treatment of influenza virus infections
EP3806629A4 (en) PURIFICATION AND CONJUGATION OF VIRUS AND ANTIGEN
MX392098B (en) POLIOMAVIRUS NEUTRALIZING ANTIBODIES.
EP4157272C0 (en) Remdesivir for the treatment of viral infections
IL280563A (en) Antibodies against BTN3A and their uses for the treatment of cancer and infectious diseases
EP4071172A4 (en) ANTI-LILRB1 ANTIBODIES AND USES THEREOF
HUE060791T2 (en) Antigenic peptides for the prevention and treatment of cancer
EP4025609A4 (en) ANTI-STEAP1 ANTIBODIES AND USES THEREOF
IL287423A (en) Antibodies and methods for treating influenza E infection
IL281730A (en) Combinations of the virus and axinia oncolytic and checkpoint suppressors of the immune system for the treatment of cancer, and pharmaceutical preparations containing these combinations
PH12017502356B1 (en) Immunoglobulin single variable domain antibody against rsv prefusion f protein
EP4519321A4 (en) ANTI-EGFR/MET ANTIBODIES AND USES THEM
EP4028422A4 (en) ANTI-CD371 ANTIBODIES AND USES THEREOF
IL286415A (en) Monoclonal antibodies for the prevention and treatment of herpes simplex viral infections
EP3793539A4 (en) Compounds for treating dengue virus infections and other infections
EP3787601C0 (en) Liposomal nanoformulation of combination antibiotics and their uses
KR102523841B9 (en) -19- An integrated quarantine system for the establishment of Corona Virus Disease-19-freezone via photo-bactericidal treatment and related systems using the same
EP4324848A4 (en) Human antibody directed against COVID-19 virus
EP3806836A4 (en) AMIDINE AND AMIDINE ANALOGUES FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIFICATION ANTIBIOTICS
EP3801485A4 (en) METHODS FOR THE PURIFICATION OF PROTEINS AND PEPTIDES
IL281447A (en) Methods and compounds for the treatment of viral infections
PL3765055T3 (en) Bacterial-binding peptides for the treatment of infectious diseases and related inflammatory processes
GB202020502D0 (en) Antibody composistion for treatment of corona virus infection
IL280340B (en) Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections